13F HOLDINGS REPORT
Soleus Capital Management, L.P.
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001802630-23-000005
Total Value
$965.7M
Positions
77
Other Managers
0
Confidential Omitted
No
Holdings (77)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 2,080,000 | $158.5M | 16.42% |
| 2 | EDAP TMS S A | EDAP | 5,312,222 | $58.8M | 6.09% |
| 3 | IVERIC BIO INC | 46583P102 | 2,127,043 | $51.8M | 5.36% |
| 4 | ARCELLX INC | ACLX | 1,248,147 | $38.5M | 3.98% |
| 5 | CHARLES RIV LABS INTL INC | 159864107 | 156,096 | $31.5M | 3.26% |
| 6 | EXACT SCIENCES CORP | 30063P105 | 456,500 | $31.0M | 3.21% |
| 7 | UNITED THERAPEUTICS CORP DEL | UTHR | 136,235 | $30.5M | 3.16% |
| 8 | IRADIMED CORP | IRMD | 773,694 | $30.4M | 3.15% |
| 9 | SMITH & NEPHEW PLC | SNNUF | 970,200 | $27.1M | 2.80% |
| 10 | ORGANOGENESIS HLDGS INC | ORGO | 9,853,063 | $21.0M | 2.17% |
| 11 | SI-BONE INC | SIBN | 1,060,983 | $20.9M | 2.16% |
| 12 | SURMODICS INC | 868873100 | 892,678 | $20.3M | 2.11% |
| 13 | CVS HEALTH CORP | CVS | 243,554 | $18.1M | 1.87% |
| 14 | CELCUITY INC | CELC | 1,687,933 | $17.3M | 1.79% |
| 15 | RIGEL PHARMACEUTICALS INC | RIGL | 12,803,015 | $16.9M | 1.75% |
| 16 | AXOGEN INC | AXGN | 1,779,998 | $16.8M | 1.74% |
| 17 | NATERA INC | NTRA | 294,200 | $16.3M | 1.69% |
| 18 | REATA PHARMACEUTICALS INC | 75615P103 | 174,592 | $15.9M | 1.64% |
| 19 | SEAGEN INC | SE | 71,000 | $14.4M | 1.49% |
| 20 | VAXCYTE INC | PCVX | 380,250 | $14.3M | 1.48% |
| 21 | THE BEAUTY HEALTH COMPANY | 88331L108 | 1,089,952 | $13.8M | 1.43% |
| 22 | JASPER THERAPEUTICS INC | JSPRW | 7,454,980 | $13.5M | 1.40% |
| 23 | ESSA PHARMA INC | 29668H708 | 4,145,117 | $12.3M | 1.27% |
| 24 | BIOATLA INC | BCAB | 4,321,197 | $11.6M | 1.20% |
| 25 | HUMANA INC | HUM | 23,750 | $11.5M | 1.19% |
| 26 | TG THERAPEUTICS INC | TGTX | 750,300 | $11.3M | 1.17% |
| 27 | NEUROPACE INC | NPCE | 2,428,714 | $11.3M | 1.17% |
| 28 | VERICEL CORP | VCEL | 326,449 | $9.6M | 0.99% |
| 29 | LANTHEUS HLDGS INC | LNTH | 113,700 | $9.4M | 0.97% |
| 30 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 1,449,777 | $8.9M | 0.92% |
| 31 | BICYCLE THERAPEUTICS PLC | BCYC | 411,800 | $8.8M | 0.91% |
| 32 | INHIBRX INC | INBX | 438,002 | $8.3M | 0.86% |
| 33 | TANDEM DIABETES CARE INC | TNDM | 203,300 | $8.3M | 0.85% |
| 34 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 469,400 | $8.1M | 0.84% |
| 35 | NOVOCURE LTD | NVCR | 130,000 | $7.8M | 0.81% |
| 36 | VIKING THERAPEUTICS INC | VKTX | 460,000 | $7.7M | 0.79% |
| 37 | 89BIO INC | 282559103 | 494,000 | $7.5M | 0.78% |
| 38 | C4 THERAPEUTICS INC | CCCC | 2,387,020 | $7.5M | 0.78% |
| 39 | THERATECHNOLOGIES INC | 88338H100 | 9,090,511 | $7.4M | 0.76% |
| 40 | KRYSTAL BIOTECH INC | KRYS | 85,179 | $6.8M | 0.71% |
| 41 | SYNDAX PHARMACEUTICALS INC | SNDX | 322,600 | $6.8M | 0.71% |
| 42 | GENEDX HOLDINGS CORP | 81663L101 | 17,940,000 | $6.5M | 0.68% |
| 43 | ALKERMES PLC | ALKS | 230,000 | $6.5M | 0.67% |
| 44 | INARI MED INC | 45332Y109 | 101,450 | $6.3M | 0.65% |
| 45 | NUVALENT INC | NUVL | 236,900 | $6.2M | 0.64% |
| 46 | KARUNA THERAPEUTICS INC | 48576A100 | 33,740 | $6.1M | 0.63% |
| 47 | BRIDGEBIO PHARMA INC | BBIO | 364,000 | $6.0M | 0.62% |
| 48 | MIRUM PHARMACEUTICALS INC | MIRM | 242,000 | $5.8M | 0.60% |
| 49 | TRAVERE THERAPEUTICS INC | TVTX | 234,600 | $5.3M | 0.55% |
| 50 | KEROS THERAPEUTICS INC | KROS | 122,316 | $5.2M | 0.54% |
| 51 | DICE THERAPEUTICS INC | 23345J104 | 173,447 | $5.0M | 0.51% |
| 52 | ENANTA PHARMACEUTICALS INC | ENTA | 116,514 | $4.7M | 0.49% |
| 53 | MINERALYS THERAPEUTICS INC | MLYS | 273,241 | $4.3M | 0.44% |
| 54 | PIERIS PHARMACEUTICALS INC | 720795103 | 4,134,868 | $4.0M | 0.42% |
| 55 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 155,000 | $3.8M | 0.39% |
| 56 | ABCAM PLC | 000380204 | 279,971 | $3.8M | 0.39% |
| 57 | INSPIRE MED SYS INC | 457730109 | 15,600 | $3.7M | 0.38% |
| 58 | ACADIA PHARMACEUTICALS INC | ACAD | 190,000 | $3.6M | 0.37% |
| 59 | ANNEXON INC | ANNX | 915,400 | $3.5M | 0.36% |
| 60 | PARAGON 28 INC | 69913P105 | 204,018 | $3.5M | 0.36% |
| 61 | PHARVARIS N V | PHVS | 336,900 | $2.7M | 0.28% |
| 62 | FIBROGEN INC | 31572Q808 | 129,463 | $2.4M | 0.25% |
| 63 | ANGIODYNAMICS INC | ANGO | 225,000 | $2.3M | 0.24% |
| 64 | ACLARIS THERAPEUTICS INC | ACRS | 249,000 | $2.0M | 0.21% |
| 65 | CARDIOVASCULAR SYS INC DEL | 141619106 | 95,346 | $1.9M | 0.20% |
| 66 | AMYLYX PHARMACEUTICALS INC | AMLX | 63,214 | $1.9M | 0.19% |
| 67 | PARDES BIOSCIENCES INC | 69945Q105 | 1,250,000 | $1.6M | 0.17% |
| 68 | TRANSMEDICS GROUP INC | TMDX | 19,000 | $1.4M | 0.15% |
| 69 | RXSIGHT INC | RXST | 80,000 | $1.3M | 0.14% |
| 70 | AXSOME THERAPEUTICS INC | AXSM | 20,700 | $1.3M | 0.13% |
| 71 | LYRA THERAPEUTICS INC | LYRA | 592,417 | $1.2M | 0.12% |
| 72 | ORCHESTRA BIOMED HLDGS INC | OBIO | 60,450 | $1.2M | 0.12% |
| 73 | PULMONX CORP | LUNG | 71,000 | $793,780 | 0.08% |
| 74 | XILIO THERAPEUTICS INC | XLO | 226,941 | $719,403 | 0.07% |
| 75 | IMMUNIC INC | IMUX | 300,000 | $447,000 | 0.05% |
| 76 | Y-MABS THERAPEUTICS INC | 984241109 | 87,182 | $436,782 | 0.05% |
| 77 | MDXHEALTH SA | MDXH | 60,000 | $194,400 | 0.02% |